Worldwide License for Mino-Lok™ is Now Complete CRANFORD, N.J., March 23, 2017, CTXR, /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has recently concluded negotiations to add South America to its worldwide license for Mino-Lok™. South America was the only territory that was not included in the original sub-license between Novel Anti-Infective Technologies, LLC, an affiliate of MD Anderson Cancer Center (“MDACC”), andRead more
- How to Choose the Right Cryptocurrency to Invest in 2018
- mCig’s Subsidiary, Grow Contractors Inc., Announces it has Secured an Exclusive Management Contract in Sacramento, CA, Paving the Way to an Expanded Presence in the State
- MoneyTV with Donald Baillargeon, 4/20
- Alternate Health Launches First Complete Ethereum Blockchain EMR / EHR
- NutraFuels, Inc. (NTFU) Provides 2017 Year End Financials Revenues Increase 694.6%
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More